IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $230,000 | -82.4% | 5,200 | -87.9% | 0.00% | -100.0% |
| Q4 2021 | $1,308,000 | -9.4% | 43,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,443,000 | -15.5% | 43,000 | +0.5% | 0.00% | -50.0% |
| Q2 2021 | $1,707,000 | +1.7% | 42,800 | +63.9% | 0.00% | 0.0% |
| Q2 2019 | $1,679,000 | -88.3% | 26,120 | -85.3% | 0.00% | -87.5% |
| Q1 2019 | $14,398,000 | +130790.9% | 177,384 | +88592.0% | 0.02% | – |
| Q4 2018 | $11,000 | -99.5% | 200 | -99.5% | 0.00% | -100.0% |
| Q3 2018 | $2,149,000 | +14.5% | 41,677 | -7.5% | 0.00% | 0.0% |
| Q2 2018 | $1,877,000 | +105.6% | 45,074 | +150.4% | 0.00% | 0.0% |
| Q3 2017 | $913,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |